[Fine Chemicals] Peptide drug synthesis methods
Peptide drug synthesis methods generally fall into two categories: biological synthesis and chemical synthesis. Biological methods include fermentation, enzymatic catalysis, and gene recombination; chemical methods include solid-phase synthesis and liquid-phase synthesis. Each has its own pros and cons, and which one to use depends on the structure of the peptide backbone. The choice of synthesis method also determines which side-chain intermediates you'll need.
Fermentation is cheap and scales well commercially, and since semaglutide uses only one non-natural amino acid (Aib) in its backbone, it's often produced by fermentation. In one fermentation route, a precursor molecule is obtained by fermentation, then combined with side chain a through chemical synthesis to get an intermediate. The tetrapeptide fragment c, which contains a non-natural amino acid, is made by solid-phase or liquid-phase synthesis, and reacting fragment c with the side-chain-bearing intermediate gives semaglutide.
Fermentation allows large-scale production at low cost, but R&D is difficult and the environmental risks are relatively high. Some peptide companies, wanting to get the API quickly, use solid-phase synthesis for semaglutide instead. Because the synthesis method differs, the intermediates used also change. Side-chain intermediates for fermentation usually don't have Lys attached, since Lys can be introduced into the backbone by fermentation, cutting costs.
Unlike semaglutide, tirzepatide introduces two non-natural amino acids into its backbone, whereas semaglutide has only one (Aib). That makes fermentation much harder for tirzepatide, and current processes basically use solid-phase synthesis to make it.
In the tirzepatide process, fragments AA1-14, AA15-21, AA22-29, and AA30-39 are made by solid-phase synthesis, then joined by liquid-phase synthesis to give the final product. The side chains used are generally the intermediate structures listed in the table.
Comments
0